[11C]Erlotinib in non-small cell lung cancer patients with and without erlotinib therapy.
Not yet recruiting
- Conditions
- on-small cell lung cancer NSCLCNiet-kleincellig longkanker
- Registration Number
- NL-OMON28948
- Lead Sponsor
- VU University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Patients with NSCLC, planned to receive erlotinib for therapy will be included in this study. Ten evaluable patients are needed. It is expected that this number of patients will be recruited within 1 year.
1. Patients age: Between 18 and 70 years;
Exclusion Criteria
1. Claustrophobia;
2. Pregnant or lactating patients;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method